CN105403707B - 一种检测靶物质的信号放大方法及使用该方法的免疫层析试纸和装置 - Google Patents
一种检测靶物质的信号放大方法及使用该方法的免疫层析试纸和装置 Download PDFInfo
- Publication number
- CN105403707B CN105403707B CN201510632056.3A CN201510632056A CN105403707B CN 105403707 B CN105403707 B CN 105403707B CN 201510632056 A CN201510632056 A CN 201510632056A CN 105403707 B CN105403707 B CN 105403707B
- Authority
- CN
- China
- Prior art keywords
- biomolecule
- molecule
- pad
- target substances
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000013076 target substance Substances 0.000 title claims abstract description 84
- 238000012360 testing method Methods 0.000 title claims abstract description 65
- 238000000034 method Methods 0.000 title claims abstract description 48
- 230000003321 amplification Effects 0.000 title abstract description 7
- 238000003199 nucleic acid amplification method Methods 0.000 title abstract description 7
- 238000001514 detection method Methods 0.000 claims abstract description 92
- 238000006243 chemical reaction Methods 0.000 claims description 23
- 239000008187 granular material Substances 0.000 claims description 23
- 238000004587 chromatography analysis Methods 0.000 claims description 19
- 230000008878 coupling Effects 0.000 claims description 18
- 238000010168 coupling process Methods 0.000 claims description 18
- 238000005859 coupling reaction Methods 0.000 claims description 18
- 230000000274 adsorptive effect Effects 0.000 claims description 17
- 238000011026 diafiltration Methods 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 14
- 239000012528 membrane Substances 0.000 claims description 12
- 238000003317 immunochromatography Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 5
- 102000039446 nucleic acids Human genes 0.000 claims description 5
- 108020004707 nucleic acids Proteins 0.000 claims description 5
- 150000007523 nucleic acids Chemical class 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 abstract description 27
- 230000035945 sensitivity Effects 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 description 24
- 238000005507 spraying Methods 0.000 description 22
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 18
- 239000000084 colloidal system Substances 0.000 description 16
- 239000010931 gold Substances 0.000 description 16
- 229910052737 gold Inorganic materials 0.000 description 16
- 239000007983 Tris buffer Substances 0.000 description 12
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 12
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
- 230000001745 anti-biotin effect Effects 0.000 description 9
- 206010064097 avian influenza Diseases 0.000 description 9
- 229920000728 polyester Polymers 0.000 description 9
- 239000000427 antigen Substances 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- 239000005018 casein Substances 0.000 description 8
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 8
- 235000021240 caseins Nutrition 0.000 description 8
- 239000002158 endotoxin Substances 0.000 description 8
- 238000002372 labelling Methods 0.000 description 8
- 229920006008 lipopolysaccharide Polymers 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 241000589562 Brucella Species 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 241000700605 Viruses Species 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 229920001213 Polysorbate 20 Polymers 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- 229960002685 biotin Drugs 0.000 description 6
- 239000011616 biotin Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 6
- 238000007654 immersion Methods 0.000 description 6
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 6
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 241001333951 Escherichia coli O157 Species 0.000 description 5
- 241001494479 Pecora Species 0.000 description 5
- 235000020958 biotin Nutrition 0.000 description 5
- 229940098773 bovine serum albumin Drugs 0.000 description 5
- 239000003365 glass fiber Substances 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 241000712431 Influenza A virus Species 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 4
- ZBKIUFWVEIBQRT-UHFFFAOYSA-N gold(1+) Chemical compound [Au+] ZBKIUFWVEIBQRT-UHFFFAOYSA-N 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 208000002672 hepatitis B Diseases 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 101150004747 omp31 gene Proteins 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 241000712461 unidentified influenza virus Species 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000555268 Dendroides Species 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000711549 Hepacivirus C Species 0.000 description 2
- 208000005176 Hepatitis C Diseases 0.000 description 2
- 241000713196 Influenza B virus Species 0.000 description 2
- 208000002979 Influenza in Birds Diseases 0.000 description 2
- 241000186779 Listeria monocytogenes Species 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 208000037798 influenza B Diseases 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 239000000700 radioactive tracer Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000011896 sensitive detection Methods 0.000 description 2
- JJGWLCLUQNFDIS-GTSONSFRSA-M sodium;1-[6-[5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]hexanoyloxy]-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)CCCCCNC(=O)CCCC[C@H]1[C@H]2NC(=O)N[C@H]2CS1 JJGWLCLUQNFDIS-GTSONSFRSA-M 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical group C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108700037148 Brucella BP26 Proteins 0.000 description 1
- 241001148106 Brucella melitensis Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108700039791 Hepatitis C virus nucleocapsid Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- GRTOGORTSDXSFK-XJTZBENFSA-N ajmalicine Chemical compound C1=CC=C2C(CCN3C[C@@H]4[C@H](C)OC=C([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 GRTOGORTSDXSFK-XJTZBENFSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 229940038698 brucella melitensis Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013098 chemical test method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000006713 insertion reaction Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000013528 metallic particle Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 238000003375 selectivity assay Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510632056.3A CN105403707B (zh) | 2015-09-29 | 2015-09-29 | 一种检测靶物质的信号放大方法及使用该方法的免疫层析试纸和装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510632056.3A CN105403707B (zh) | 2015-09-29 | 2015-09-29 | 一种检测靶物质的信号放大方法及使用该方法的免疫层析试纸和装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105403707A CN105403707A (zh) | 2016-03-16 |
CN105403707B true CN105403707B (zh) | 2017-05-17 |
Family
ID=55469316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510632056.3A Active CN105403707B (zh) | 2015-09-29 | 2015-09-29 | 一种检测靶物质的信号放大方法及使用该方法的免疫层析试纸和装置 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105403707B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107643399A (zh) * | 2017-03-06 | 2018-01-30 | 广州佰芮慷生物科技有限公司 | 一种提高免疫检测系统灵敏性的方法及使用该方法的装置 |
CN109765383B (zh) * | 2019-01-29 | 2022-11-18 | 北京勤邦生物技术有限公司 | 一种猫瘟热病毒抗体荧光检测试纸条及其制备方法和应用 |
CN112881672A (zh) * | 2021-01-11 | 2021-06-01 | 南京钟鼎生物技术有限公司 | 通用型多核酸产物检测胶体金试纸条及其制备方法和应用 |
CN112666347B (zh) * | 2021-03-17 | 2021-07-06 | 广州敏捷生物技术有限公司 | 同步检测植物油中黄曲霉毒素b1、玉米赤霉烯酮含量的免疫荧光层析试剂盒及方法 |
CN116024302B (zh) * | 2022-10-26 | 2023-08-01 | 江苏迅睿生物技术有限公司 | 双联核酸检测层析试纸、引物及探针组、试剂盒 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1500212A (zh) * | 2000-11-30 | 2004-05-26 | ���ס�����˹���� | 有多个被标记部分的信号增强系统 |
EP1301627B1 (en) * | 2000-07-07 | 2009-01-21 | Diagnostics for the Real World, Ltd | Improved detection signal and capture in dipstick assays |
CN101865921A (zh) * | 2010-06-11 | 2010-10-20 | 中国检验检疫科学研究院 | 一种检测菜豆荚斑驳病毒的方法及专用试剂盒 |
CN102227631A (zh) * | 2008-11-28 | 2011-10-26 | 英佛皮亚有限公司 | 免疫层析测试中信号放大的方法以及使用该方法的免疫层析试剂盒 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7108976B2 (en) * | 2002-06-17 | 2006-09-19 | Affymetrix, Inc. | Complexity management of genomic DNA by locus specific amplification |
-
2015
- 2015-09-29 CN CN201510632056.3A patent/CN105403707B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1301627B1 (en) * | 2000-07-07 | 2009-01-21 | Diagnostics for the Real World, Ltd | Improved detection signal and capture in dipstick assays |
CN1500212A (zh) * | 2000-11-30 | 2004-05-26 | ���ס�����˹���� | 有多个被标记部分的信号增强系统 |
CN102227631A (zh) * | 2008-11-28 | 2011-10-26 | 英佛皮亚有限公司 | 免疫层析测试中信号放大的方法以及使用该方法的免疫层析试剂盒 |
CN101865921A (zh) * | 2010-06-11 | 2010-10-20 | 中国检验检疫科学研究院 | 一种检测菜豆荚斑驳病毒的方法及专用试剂盒 |
Non-Patent Citations (1)
Title |
---|
胶体金核酸层析检测5种检疫性植物病毒的研究;曹成;《中国优秀硕士学位论文全文数据库(农业科技辑)》;20130215(第2期);正文2.1.4、2.2.3.5、2.2.5部分,"第四章 讨论"部分 * |
Also Published As
Publication number | Publication date |
---|---|
CN105403707A (zh) | 2016-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105403707B (zh) | 一种检测靶物质的信号放大方法及使用该方法的免疫层析试纸和装置 | |
CN105486854B (zh) | 一种信号放大方法及相关装置 | |
JP2638600B2 (ja) | 免疫診断装置 | |
CN101441210A (zh) | 纳米磁性粒子层析试纸检测方法 | |
JPH0595799A (ja) | 少なくとも二つの結合成分に対する結合部位を有する測定物質の検出 | |
CN102236022B (zh) | 一种检测装置 | |
WO2015119386A1 (ko) | 효소 모방 무기 나노입자를 이용한 고감도 측면유동 면역 발색칩 및 이를 이용한 검출 방법 | |
WO2000002049A1 (fr) | Test immunologique et kit de test immunologique | |
CN107643399A (zh) | 一种提高免疫检测系统灵敏性的方法及使用该方法的装置 | |
Wang et al. | Development of an immunochromatographic test to detect white spot syndrome virus of shrimp | |
CN102135541A (zh) | 阪崎肠杆菌检测方法及其金标快速诊断试剂盒和制备方法 | |
CN102565382A (zh) | 一种检测血液样本中过敏原特异性IgE抗体的免疫层析方法 | |
JP4503334B2 (ja) | 免疫測定に供する検体浮遊液調製用媒体組成物及びそれを用いる免疫測定方法 | |
CN209690322U (zh) | 一种肺炎衣原体抗体检测试纸盒 | |
CN103823061A (zh) | Au/Fe3O4免疫层析试纸条及其制备方法与应用 | |
WO2017163341A1 (ja) | イムノクロマト法検査デバイスの試料添加部の形成方法及びイムノクロマト法検査デバイス | |
CN106526166A (zh) | 猪肉中瘦肉精的快速检测 | |
CN102388312B (zh) | 分析方法、样品分析用具、防止样品液逆流的方法和防止背景上升的方法 | |
CN112114134B (zh) | 靶物质检测方法、靶物质检测试剂盒以及靶物质检测系统 | |
CN105738616A (zh) | 双重放大荧光免疫标记探针的制备方法及应用、用其制备荧光免疫层析试剂条的方法 | |
CN101852802A (zh) | 一种一步检测鸡新城疫和传染性支气管炎病毒的试纸条 | |
JP3930970B2 (ja) | 免疫学的検査方法および免疫学的検査用キット | |
JP2000028614A (ja) | 免疫学的検査方法および免疫学的検査キット | |
CN104391118B (zh) | 降钙素原的检测装置、以及检测材料的制备方法 | |
CN109164265A (zh) | 疫苗抗体检测卡及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210519 Address after: 510700 Room 403, building A5, No.3, scientific research road, Science City, Huangpu District, Guangzhou City, Guangdong Province Patentee after: GUANGZHOU BAIRUIKANG BIOTECHNOLOGY Co.,Ltd. Address before: South Medical University, 1838 Guangzhou Avenue North, Guangzhou, Guangdong 510515 Patentee before: SOUTHERN MEDICAL University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220706 Address after: Room 301, building a, No. 18, rongshuzhao Industrial Zone, Tongxin community, Baolong street, Longgang District, Shenzhen City, Guangdong Province Patentee after: MIRACLEAN TECHNOLOGY Co.,Ltd. Address before: 510700 Room 403, building A5, No.3, scientific research road, Science City, Huangpu District, Guangzhou City, Guangdong Province Patentee before: GUANGZHOU BAIRUIKANG BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231031 Address after: Building 6, 201, Yinxing Life and Health Science Park, No. 19 Linhui Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen City, Guangdong Province, 518000 Patentee after: Jianguo Biotechnology (Shenzhen) Co.,Ltd. Address before: Room 301, building a, No. 18, rongshuzhao Industrial Zone, Tongxin community, Baolong street, Longgang District, Shenzhen City, Guangdong Province Patentee before: MIRACLEAN TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |